Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Calgary

$100,000.00

Roles of Sex and Gender in the Prevention of Coronary Artery Disease: The Example of Heat Shock Protein 27 as a Menopausal Cardiovascular Biomarker and Potential Anti-Atherosclerosis Therapy

EF 2016-17

Résumé
The most common fatal heart problem is a heart attack when the arteries that supply oxygen to your heart muscle are blocked (also known as coronary artery disease, CAD). There is a critical need to better understand how and why heart disease occurs, and what can be done to lower the risk of developing heart disease. CAD occurs more commonly as you get older. In women, the risk increases after menopause (when ovarian sex function has declined). In men, CAD may also be associated with male menopause, when males become less virile. While these biological changes of menopause can be associated with health problems such as CAD, they also are associated with factors that change the way individuals think about themselves or how society views them. Such changes in perception represent changes in gender. We now explore how these two inter-related concepts, sex and gender, influence the risk, perception and management of CAD in males and females. In particular, we will try to highlight some of the biological changes that occur with menopause (e.g., changes in hormones, that result in downstream biological effects - including the loss of a protein in the blood called HSP27), and correlate them with CAD management / outcomes. As well, we will use HSP27 as an example of a predictive measurement and potential new treatment for the management of menopause-related increases in CAD. For example, we will pursue a series of experiments in animals whereby the administration of HSP27 (or smaller parts of this protein) will be given as "replacement therapy" to boost low levels of HSP27 in order to prevent hardening of the arteries. Finally, special proteins (called antibodies) can "stick" to HSP27 and surprisingly make HSP27 more potent. Therefore, we will explore the use immunization strategies to generate more antibodies to HSP27 that might strengthen the potency of HSP27 in treating hardening of the arteries.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
351767
Name
O'Brien Edward R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Roles of Sex and Gender in the Prevention of Coronary Artery Disease: The Example of Heat Shock Protein 27 as a Menopausal Cardiovascular Biomarker and Potential Anti-Atherosclerosis Therapy
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antibodies; Atherosclerosis; Cholesterol; Gender; Heat Shock Proteins; Hormones; Immunization; Micro-Rna; Pcsk9; Sex
Abstract
The most common fatal heart problem is a heart attack when the arteries that supply oxygen to your heart muscle are blocked (also known as coronary artery disease, CAD). There is a critical need to better understand how and why heart disease occurs, and what can be done to lower the risk of developing heart disease. CAD occurs more commonly as you get older. In women, the risk increases after menopause (when ovarian sex function has declined). In men, CAD may also be associated with male menopause, when males become less virile. While these biological changes of menopause can be associated with health problems such as CAD, they also are associated with factors that change the way individuals think about themselves or how society views them. Such changes in perception represent changes in gender. We now explore how these two inter-related concepts, sex and gender, influence the risk, perception and management of CAD in males and females. In particular, we will try to highlight some of the biological changes that occur with menopause (e.g., changes in hormones, that result in downstream biological effects - including the loss of a protein in the blood called HSP27), and correlate them with CAD management / outcomes. As well, we will use HSP27 as an example of a predictive measurement and potential new treatment for the management of menopause-related increases in CAD. For example, we will pursue a series of experiments in animals whereby the administration of HSP27 (or smaller parts of this protein) will be given as "replacement therapy" to boost low levels of HSP27 in order to prevent hardening of the arteries. Finally, special proteins (called antibodies) can "stick" to HSP27 and surprisingly make HSP27 more potent. Therefore, we will explore the use immunization strategies to generate more antibodies to HSP27 that might strengthen the potency of HSP27 in treating hardening of the arteries.
Competitiondate
201604
Approvedterm2
1 yr 0 mth
Pinamesdelim
O'Brien, Edward R; Aggarwal, Sandeep G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~